As of 05 Nov 2026 09:09 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2026/040 (26 Aug 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Venlafaxine 75mg immediate release (IR) tabletsaffected product · inferred from phrasing | Out of stock, as stated | November 2026precision: a month · window end 30 Nov 2026, derived from “November 2026” | notice of 26 Aug 2026 |
| Venlafaxine 150mg modified release (MR) capsulesnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 26 Aug 2026 |
| Venlafaxine 37.5mg and 75mg MR capsulesnamed by the source as remaining available · inferred from phrasing | Stated as available; can support only a partial uplift | — not stated for this line | notice of 26 Aug 2026 |
| Venlafaxine 75mg MR tabletsnamed by the source as remaining available · inferred from phrasing | Stated as available; can support only a partial uplift | — not stated for this line | notice of 26 Aug 2026 |
| Venlafaxine 37.5mg IR tabletsnamed by the source as remaining available · inferred from phrasing | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 26 Aug 2026 |
| Venlafaxine 37.5mg,150mg, 225mg and 300mg MR tabletsnamed by the source as remaining available · inferred from phrasing | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 26 Aug 2026 |
| Venlafaxine 225mg and 300mg MR capsulesnamed by the source as remaining available · inferred from phrasing | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 26 Aug 2026 |
| Venlafaxine 37.5mg/5ml and 75mg/5ml oral solutionsnamed by the source as remaining available · inferred from phrasing | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 26 Aug 2026 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register — 1 earlier protocol on this record has expired: SSP083 (to 01 Aug 2025). Matching is by name until identifier coding lands.
Named in the source as remaining available
- Venlafaxine 150mg modified release (MR) capsules — named by the source as remaining available (inferred from phrasing)
- Venlafaxine 37.5mg and 75mg MR capsules — named by the source as remaining available (inferred from phrasing)
- Venlafaxine 75mg MR tablets — named by the source as remaining available (inferred from phrasing)
- Venlafaxine 37.5mg IR tablets — named by the source as remaining available (inferred from phrasing)
- Venlafaxine 37.5mg,150mg, 225mg and 300mg MR tablets — named by the source as remaining available (inferred from phrasing)
- Venlafaxine 225mg and 300mg MR capsules — named by the source as remaining available (inferred from phrasing)
- Venlafaxine 37.5mg/5ml and 75mg/5ml oral solutions — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Venlafaxine
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 2 times on record since 2025 — a recurring shortage spanning 1.2 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 26 Aug 2026 | Medicine Supply Notification: Venlafaxine 75mg immediate-release tablets | Supply notification | Tier 2 | MSN/2026/040 |
| 13 Jun 2025 | Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets | Supply notification | Tier 2 | MSN/2025/035 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2026)29 Venlafaxine 75mg immediate-release tablets · issued 28 Aug 2026 · valid until late November 2026, as stated · matched by name PDF ↗
- MSAN(2025)28 Venlafaxine 37.5mg modified release tablets · issued 18 Jun 2025 · valid until mid-July 2025, as stated · matched by name PDF ↗